Logo image of ALROC.PA

ROCTOOL (ALROC.PA) Stock Fundamental Analysis

EPA:ALROC - Euronext Paris - Matif - FR0010523167 - Common Stock - Currency: EUR

0.27  -0.03 (-9.7%)

Fundamental Rating

2

Taking everything into account, ALROC scores 2 out of 10 in our fundamental rating. ALROC was compared to 104 industry peers in the Machinery industry. ALROC scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ALROC does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

ALROC had negative earnings in the past year.
In the past year ALROC has reported a negative cash flow from operations.
In the past 5 years ALROC always reported negative net income.
ALROC had negative operating cash flow in 4 of the past 5 years.
ALROC.PA Yearly Net Income VS EBIT VS OCF VS FCFALROC.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1M -1M -2M -3M -4M

1.2 Ratios

The Return On Assets of ALROC (-40.49%) is worse than 93.27% of its industry peers.
Looking at the Return On Equity, with a value of -98.84%, ALROC is doing worse than 90.38% of the companies in the same industry.
Industry RankSector Rank
ROA -40.49%
ROE -98.84%
ROIC N/A
ROA(3y)-6.93%
ROA(5y)-16.19%
ROE(3y)-32.01%
ROE(5y)-47.48%
ROIC(3y)N/A
ROIC(5y)N/A
ALROC.PA Yearly ROA, ROE, ROICALROC.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 -20 -40 -60

1.3 Margins

The Gross Margin of ALROC (56.98%) is better than 79.81% of its industry peers.
In the last couple of years the Gross Margin of ALROC has remained more or less at the same level.
ALROC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 56.98%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.92%
GM growth 5Y-1.08%
ALROC.PA Yearly Profit, Operating, Gross MarginsALROC.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 60

4

2. Health

2.1 Basic Checks

ALROC does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALROC has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ALROC has been increased compared to 5 years ago.
The debt/assets ratio for ALROC is higher compared to a year ago.
ALROC.PA Yearly Shares OutstandingALROC.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M
ALROC.PA Yearly Total Debt VS Total AssetsALROC.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

2.2 Solvency

ALROC has an Altman-Z score of -3.11. This is a bad value and indicates that ALROC is not financially healthy and even has some risk of bankruptcy.
ALROC has a Altman-Z score of -3.11. This is amonst the worse of the industry: ALROC underperforms 82.69% of its industry peers.
ALROC has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.31, ALROC is in line with its industry, outperforming 52.88% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z -3.11
ROIC/WACCN/A
WACC6.67%
ALROC.PA Yearly LT Debt VS Equity VS FCFALROC.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M -4M 6M

2.3 Liquidity

ALROC has a Current Ratio of 3.29. This indicates that ALROC is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.29, ALROC belongs to the top of the industry, outperforming 91.35% of the companies in the same industry.
ALROC has a Quick Ratio of 2.62. This indicates that ALROC is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of ALROC (2.62) is better than 93.27% of its industry peers.
Industry RankSector Rank
Current Ratio 3.29
Quick Ratio 2.62
ALROC.PA Yearly Current Assets VS Current LiabilitesALROC.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M

1

3. Growth

3.1 Past

ALROC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -499.41%.
The Revenue for ALROC has decreased by -32.93% in the past year. This is quite bad
Measured over the past years, ALROC shows a small growth in Revenue. The Revenue has been growing by 4.55% on average per year.
EPS 1Y (TTM)-499.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-17417.65%
Revenue 1Y (TTM)-32.93%
Revenue growth 3Y11.45%
Revenue growth 5Y4.55%
Sales Q2Q%-40.72%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALROC.PA Yearly Revenue VS EstimatesALROC.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M
ALROC.PA Yearly EPS VS EstimatesALROC.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 -0.2 -0.4 -0.6

0

4. Valuation

4.1 Price/Earnings Ratio

ALROC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALROC.PA Price Earnings VS Forward Price EarningsALROC.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALROC.PA Per share dataALROC.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ALROC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ROCTOOL

EPA:ALROC (8/5/2025, 7:00:00 PM)

0.27

-0.03 (-9.7%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.84%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.84M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.27
P/FCF N/A
P/OCF N/A
P/B 0.61
P/tB 1.11
EV/EBITDA N/A
EPS(TTM)-0.51
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.32
FCFYN/A
OCF(TTM)-0.25
OCFYN/A
SpS1.02
BVpS0.44
TBVpS0.24
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -40.49%
ROE -98.84%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 56.98%
FCFM N/A
ROA(3y)-6.93%
ROA(5y)-16.19%
ROE(3y)-32.01%
ROE(5y)-47.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.92%
GM growth 5Y-1.08%
F-Score3
Asset Turnover0.94
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 146.77%
Cap/Sales 6.14%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.29
Quick Ratio 2.62
Altman-Z -3.11
F-Score3
WACC6.67%
ROIC/WACCN/A
Cap/Depr(3y)136.76%
Cap/Depr(5y)105.98%
Cap/Sales(3y)5.06%
Cap/Sales(5y)5.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-499.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-17417.65%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-32.93%
Revenue growth 3Y11.45%
Revenue growth 5Y4.55%
Sales Q2Q%-40.72%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2832.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-4.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y0.1%
OCF growth 3YN/A
OCF growth 5YN/A